Artera Earns Frost & Sullivan’s 2026 Technology Innovation Leadership Recognition for AI-Powered Breast Cancer Risk Stratification

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced it received Frost & Sullivan’s 2026 North American Technology Innovation Leadership Recognition for AI-powered breast cancer risk stratification. The recognition highlights Artera’s approach to translating multimodal AI and clinical evidence into personalized cancer risk insights. ArteraAI Breast uses digitized routine pathology ima

The post Artera Earns Frost & Sullivan’s 2026 Technology Innovation Leadership Recognition for AI-Powered Breast Cancer Risk Stratification appeared first on BusinessWire.

For more information, please visit http://www.businesswire.com/news/home/20261029682521/en/Artera-Earns-F…